Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHIMU Okinawa Study: Clopidogrel vs prasugrel platelet aggregation in ischemic heart disease
jRCTs071180054Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of clopidogrel and prasugrel in coronary arteriosclerosis (2 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Platelet aggregation ability (PRU in VerifyNow). Started Mar 2017; status: completed.
02
Drugs
clopidogrelprasugrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on jRCTs071180054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071180054.